August 26, 2019
Bi-WEEKLY RECAP OF PORTFOLIO COMPANIES IN THE NEWS:
- 1933 Industries Transfers Cannabis Plants to its New Cultivation Facility in Nevada, Initiating New Growth Period and Expanding Product Offerings
- Next Green Wave SuccesSfully completes first Premium Cannabis Harvest
- Bhang CEO’s Scott Van Rixels’ Interview with New cannabis ventures
- Avicanna completes First Export From Columbia to Canada
1933 Industries Inc. (“1933 Industries”, TSX: TGIF), part of CGOC’s public portfolio, is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada.
August 20, 2019 – 1933 Industries announced that it commenced the transfer of cannabis plants to its new cultivation facility in Las Vegas following an extensive period of systems-wide testing. OG DNA Genetics (DNA), a globally recognized leader in the research and development of cannabis genetics, will partner with 1933 Industries at their new facility.
Next Green Wave Solutions (“Next Green Wave”, CSE: NGW), part of CGOC’s public portfolio, is a vertically integrated producer, building out a product line of THC and CBD derived products known as one of California’s best consumer packaged goods brands.
August 22, 2019 – Next Green Wave announced the successful completion of its first premium cannabis flower harvest, as well as hitting all major milestones to become fully operational this month. All fourteen (14) flower rooms have now been stocked with plants, six (6) of which are in the flowering stage and nearing harvest. The future output will allow Next Green Wave to execute on its four planned revenue segments including nursery, cultivation, extraction and products distribution.
Bhang Inc. (“Bhang”, CSE: BHN:), part of CGOC’s public portfolio, is a global cannabis house of brands with an extensive, award-winning portfolio of products.
August 22, 2019 – Bhang’s CEO, Scott Van Rixel discusses Bhang’s commitment to its “Brand Matters Most”, philosophy in his most recent interview with New Cannabis Ventures. In his interview, Mr. Van Rixel discusses how the company has transformed from a chocolate-focussed cannabis company nine years ago, to today, where its house of brands span edibles, tinctures, pre-rolls, vapes, CBD products and much more.
Avicanna Inc. (“Avicanna”, TSX: AVCN), part of CGOC’s public portfolio, is a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products.
August 23, 2019 – Avicanna announced completion of its first export of purified cannabadoil (“CBD”) from its operations in Columbia to Canada for research and development purposes. The export required approvals from both Health Canada and Columbian National Narcotics Fund, which were granted to Avicanna’s cultivation subsidiary SMGH.
|E-UPDATES – Sign up here to be included in our email blasts and receive timely updates
For further information please contact Cannabis Growth Opportunity Corporation: